215 related articles for article (PubMed ID: 9315058)
1. Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases.
Degiuli M; Sasako M; Ponzetto A; Allone T; Soldati T; Calgaro M; Balcet F; Bussone R; Olivieri F; Scaglione D; Danese F; Morino M; Calderini P; Capussotti L; Fronda G; Garavoglia M; Locatelli L; Dellepiane M; Rossini FP; Calvo F
Eur J Surg Oncol; 1997 Aug; 23(4):310-4. PubMed ID: 9315058
[TBL] [Abstract][Full Text] [Related]
2. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Calvo F
Br J Cancer; 2004 May; 90(9):1727-32. PubMed ID: 15150592
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study.
Degiuli M; Sasako M; Ponti A; Soldati T; Danese F; Calvo F
J Clin Oncol; 1998 Apr; 16(4):1490-3. PubMed ID: 9552056
[TBL] [Abstract][Full Text] [Related]
4. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients.
Biffi R; Chiappa A; Luca F; Pozzi S; Lo Faso F; Cenciarelli S; Andreoni B
J Surg Oncol; 2006 Apr; 93(5):394-400. PubMed ID: 16550575
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
6. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
[TBL] [Abstract][Full Text] [Related]
7. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.
Cuschieri A; Fayers P; Fielding J; Craven J; Bancewicz J; Joypaul V; Cook P
Lancet; 1996 Apr; 347(9007):995-9. PubMed ID: 8606613
[TBL] [Abstract][Full Text] [Related]
8. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
9. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.
Sano T; Sasako M; Yamamoto S; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K
J Clin Oncol; 2004 Jul; 22(14):2767-73. PubMed ID: 15199090
[TBL] [Abstract][Full Text] [Related]
10. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility, safety and long-term efficacy of laparoscopic total gastrectomy combined with distal pancreaticosplenectomy for T4b gastric cancer].
Zhou SN; Yang B; Tan JN; Huang J; Chen ZT; Zheng SY; Gao H; Zhang YC; Wen LQ; Han FH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):163-169. PubMed ID: 32074797
[No Abstract] [Full Text] [Related]
12. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
13. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
15. Short-term surgical outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer.
Shi Y; Xu X; Zhao Y; Qian F; Tang B; Hao Y; Luo H; Chen J; Yu P
Surg Endosc; 2018 May; 32(5):2427-2433. PubMed ID: 29234941
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer: Current status of lymph node dissection.
Degiuli M; De Manzoni G; Di Leo A; D'Ugo D; Galasso E; Marrelli D; Petrioli R; Polom K; Roviello F; Santullo F; Morino M
World J Gastroenterol; 2016 Mar; 22(10):2875-93. PubMed ID: 26973384
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
Schmid A; Thybusch A; Kremer B; Henne-Bruns D
Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
[TBL] [Abstract][Full Text] [Related]
19. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons.
Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
Hepatogastroenterology; 2006; 53(69):389-94. PubMed ID: 16795979
[TBL] [Abstract][Full Text] [Related]
20. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
